Brief: VolitionRx Announces Proof Of Concept Data In Lymphoma And Leukemia
03/12/2019 16:06
Dec 3 (Reuters) - VolitionRx Ltd VNRX.N :
* VOLITIONRX LIMITED ANNOUNCES PROOF OF CONCEPT DATA IN
LYMPHOMA
AND LEUKEMIA
Source text for Eikon: ID:nPnVrwTba
Further company coverage: VNRX.N
Recent news on VolitionRX
See all newsBrief: Volitionrx -Files Preliminary Prospectus For 10,006,360 Shares Of Common Stock Offered By Selling Stockholder - SEC Filing
Brief: Volitionrx - Advances Nu.Q Nets Platform Towards Commercialization
Brief: VolitionRX Limited Announces First Quarter 2026 Financial Results
Brief: Volition Reports Breakthrough In Liquid Biopsy Achievement Of Over 99% Purity In Isolating Cancer Dna
Brief: Volition Announces First Ever Automated Nu.Q® Vet Cancer Test With Fujifilm Vet Systems